LEE011 (ribociclib)

ribociclib · Novartis

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LEE011 (ribociclib), covering 2016-01-01 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors [Phase 2]